GOVX Valuation

GeoVax Labs Inc

Add to Watchlist

Advanced Chart

0.566

+0.003(0.533%)1D

GOVX Relative Valuation

GOVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOVX is overvalued; if below, it's undervalued.

Historical Valuation

GeoVax Labs Inc (GOVX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.57 is considered Fairly compared with the five-year average of -1.66. The fair price of GeoVax Labs Inc (GOVX) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：0.57

Fair

-0.34

Trailing

Forward

0.00

EV/EBITDA

GeoVax Labs Inc. (GOVX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.41. The thresholds are as follows: Strongly Undervalued below -6.18, Undervalued between -6.18 and -3.30, Fairly Valued between 2.47 and -3.30, Overvalued between 2.47 and 5.36, and Strongly Overvalued above 5.36. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-0.58

EV/EBIT

GeoVax Labs Inc. (GOVX) has a current EV/EBIT of -0.58. The 5-year average EV/EBIT is -0.34. The thresholds are as follows: Strongly Undervalued below -2.23, Undervalued between -2.23 and -1.29, Fairly Valued between 0.61 and -1.29, Overvalued between 0.61 and 1.55, and Strongly Overvalued above 1.55. The current Forward EV/EBIT of -0.58 falls within the Historic Trend Line -Fairly Valued range.

0.57

GeoVax Labs Inc. (GOVX) has a current PS of 0.57. The 5-year average PS is 58.44. The thresholds are as follows: Strongly Undervalued below -176.68, Undervalued between -176.68 and -59.12, Fairly Valued between 176.00 and -59.12, Overvalued between 176.00 and 293.56, and Strongly Overvalued above 293.56. The current Forward PS of 0.57 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

GeoVax Labs Inc. (GOVX) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.10. The thresholds are as follows: Strongly Undervalued below -7.40, Undervalued between -7.40 and -4.25, Fairly Valued between 2.06 and -4.25, Overvalued between 2.06 and 5.21, and Strongly Overvalued above 5.21. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

GeoVax Labs Inc. (GOVX) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.38. The thresholds are as follows: Strongly Undervalued below -7.31, Undervalued between -7.31 and -4.34, Fairly Valued between 1.59 and -4.34, Overvalued between 1.59 and 4.56, and Strongly Overvalued above 4.56. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

GeoVax Labs Inc (GOVX) has a current Price-to-Book (P/B) ratio of 3.19. Compared to its 3-year average P/B ratio of 97.32 , the current P/B ratio is approximately -96.72% higher. Relative to its 5-year average P/B ratio of 58.60, the current P/B ratio is about -94.55% higher. GeoVax Labs Inc (GOVX) has a Forward Free Cash Flow (FCF) yield of approximately -163.05%. Compared to its 3-year average FCF yield of -204.20%, the current FCF yield is approximately -20.15% lower. Relative to its 5-year average FCF yield of -142.77% , the current FCF yield is about 14.20% lower.

3.19

P/B

Median3y

97.32

Median5y

58.60

-163.05

FCF Yield

Median3y

-204.20

Median5y

-142.77

Competitors Valuation Multiple

The average P/S ratio for GOVX's competitors is 1.46, providing a benchmark for relative valuation. GeoVax Labs Inc Corp (GOVX) exhibits a P/S ratio of 0.57, which is -61.38% above the industry average. Given its robust revenue growth of 183.45%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Chemomab Therapeutics Ltd

Adaptimmune Therapeutics PLC

Performance Decomposition

Market capitalization of GOVX decreased by 78.57% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 300.68K to 852.28K.

The secondary factor is the Margin Expansion, contributed -62.59%to the performance.

Overall, the performance of GOVX in the past 1 year is driven by Revenue Growth. Which is more sustainable.

183.45%

300.68K → 852.28K

Revenue Growth

-62.59%

-1.68K → -630.05

Margin Expansion

-199.43%

0.25 → -0.25

P/E Change

-78.57%